Mevacor OTC opinions
This article was originally published in The Tan Sheet
American Pharmacists Association supports a "strong role" for pharmacists if an Rx-to-OTC switch of lovastatin 20 mg were to be approved, former APhA President Janet Engle says Jan. 14. An APhA task force developed the "pharmacy care OTC" category for drugs to treat chronic, asymptomatic conditions last fall (1"The Tan Sheet" Nov. 8, 2004, p. 10). J&J/Merck says OTC Mevacor should be sold only in retail outlets with a pharmacy. FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees voted 20-3 against the switch...
You may also be interested in...
A new category of "pharmacy care" drugs could broaden access to certain over-the-counter drugs, according to the American Pharmacists Association
ANGLE plc’s Parsortix system could become the first FDA-cleared device for harvesting intact cancer cells from a blood sample. See what CEO Andrew Newlands said about its potential benefits.
Phase III protocols for COVID-19 vaccine candidates from Pfizer/BioNTech, Moderna, AstraZeneca and Johnson & Johnson are similar – but definitely not the same.